DOCSLIB.ORG

Brain-Specific Knock-Out of Hypoxia-Inducible Factor-1Α

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Brain-Specific Knock-Out of Hypoxia-Inducible Factor-1Α The Journal of Neuroscience, April 20, 2005 • 25(16):4099–4107 • 4099 Neurobiology of Disease Brain-Specific Knock-Out of Hypoxia-Inducible Factor-1␣ Reduces Rather Than Increases Hypoxic–Ischemic Damage Rob Helton,1* Jiankun Cui,2* John R. Scheel,1* Julie A. Ellison,1 Chris Ames,1 Claire Gibson,2 Barbara Blouw,3 Ling Ouyang,1 Ioannis Dragatsis,4 Scott Zeitlin,5 Randall S. Johnson,3 Stuart A. Lipton,2 and Carrolee Barlow1 1Laboratory of Genetics, The Salk Institute for Biological Studies, and 2Center for Neuroscience and Aging, The Burnham Institute, La Jolla, California 92037, 3Molecular Biology Section, Division of Biology, University of California, San Diego, La Jolla, California 92093, 4Department of Physiology, The University of Tennessee, Health Science Center, Memphis, Tennessee 38163, and 5Department of Neuroscience, University of Virginia School of Medicine, Charlottesville, Virginia 22908 ␣ ␣ Hypoxia-inducible factor-1 (HIF-1 ) plays an essential role in cellular and systemic O2 homeostasis by regulating the expression of genes important in glycolysis, erythropoiesis, angiogenesis, and catecholamine metabolism. It is also believed to be a key component of the cellular response to hypoxia and ischemia under pathophysiological conditions, such as stroke. To clarify the function of HIF-1␣ in the brain, we exposed adult mice with late-stage brain deletion of HIF-1␣ to hypoxic injuries. Contrary to expectations, the brains from the HIF-1␣-deficient mice were protected from hypoxia-induced cell death. These surprising findings suggest that decreas- ing the level of HIF-1␣ can be neuroprotective. Gene chip expression analysis revealed that, contrary to expectations, the majority of hypoxia-dependent gene-expression changes were unaltered, whereas a specific downregulation of apoptotic genes was observed in the HIF-1␣-deficient mice. Although the role of HIF-1␣ has been extensively characterized in vitro, in cancer models, and in chronic preconditioning paradigms, this is the first study to evaluate the role of HIF-1␣ in vivo in the brain in response to acute hypoxia/ischemia. Our data suggest, that in acute hypoxia, the neuroprotection found in the HIF-1␣-deficient mice is mechanistically consistent with a predominant role of HIF-1␣ as proapoptotic and loss of function leads to neuroprotection. Furthermore, our data suggest that functional redundancy develops after excluding HIF-1␣, leading to the preservation of gene expression regulating the majority of other previously characterized HIF-dependent genes. Key words: apoptosis; carotid; hippocampus; hypoxia; neuron; transcription Introduction tutively expressed subunit, HIF-1␤, and a subunit that is tightly ␣ The ability of cells and an organism to adapt to periods of hypoxia regulated by the cellular O2 concentration, HIF-1 (Wenger, is important for their survival in both physiological and patho- 2002). HIF-1␣ is the primary mammalian transcription factor physiological states (Bunn and Poyton, 1996). Hypoxia inducible specifically regulated by hypoxia; thus, HIF-1␣ and the genes factor-1 (HIF-1) is a basic helix-loop-helix (HLH) heterodimeric regulated by it have been the center of intense research because of transcription factor that is thought to play a major role in the their potential as therapeutic targets for ameliorating the effects response to hypoxia (Semenza, 2000). HIF-1 consists of a consti- of ischemia in a clinical setting. HIF-1␣ regulates genes that are important in tissue survival, such as vascular endothelial growth factor (VEGF), which has Received Nov. 5, 2004; revised Feb. 17, 2005; accepted Feb. 18, 2005. been shown to induce vasculogenesis and angiogenesis in many This work was supported by the Frederick B. Rentschler Developmental Chair, National Institute of Neurological ␣ Disorders and Stroke Grant NS039601-04 (C.B.), National Institutes of Health (NIH) Grants F31 NS10860-01 (J.R.S.), organ systems. Although HIF-1 is essential for adaptation to PO1 HD29587, R01 EY05477, R01 NS47973, R01 NS44326, R01 NS46994, and R01 NS43242, an Ellison Medical low oxygen levels, it has also been shown in vitro to mediate Foundation Senior Scholar Award (S.A.L.), and Microarray Core support by NIH Cancer Core Grant CA014195 (L.O.). hypoxia-induced growth arrest and apoptosis (Goda et al., 2003). We acknowledge the following: David Lockhart for scientific insights and support of this project; David and Dan Genetic studies to evaluate more precisely the role of HIF-1␣ in Lockhart for programming of the BullFrog software; Information Management Consultants (McLean, VA) and Tera- data (NCR, Dayton, OH) for donating the Teradata database and programming of the Teragenomics database; the organism had been hampered as a complete deletion leads to Ingenuity Systems for donation of the software and for figure preparation; Donna Ferriero and Howard Federoff for embryonic lethality (Ryan et al., 1998). Additional studies using scientificinsightsandsupportofthisproject;KathyChungandEmilyAnnasforassistancewithQ-PCRanalysis;Peter animals with tissue and organ deletions during development have Wagner for the use of the hypoxia chamber; and GOTree for analysis and programming. Additionally, we thank C. also been difficult to interpret because of developmental abnor- Doane and Jamie Simon for assistance with preparation of this manuscript. *R.H., J.C., and J.R.S. contributed equally to this work. malities (Ryan et al., 1998; Tomita et al., 2003). Correspondenceshouldbeaddressedtoeitherofthefollowing:CarroleeBarlow,LaboratoryofGenetics,TheSalk To understand the function of HIF-1␣ in the adult brain in Institute for Biological Studies, 10100 North Torrey Pines Road, La Jolla, CA 92037, E-mail: [email protected] or response to acute hypoxia, we generated mice with a late-stage [email protected]; or Stuart A. Lipton, Center for Neuroscience and Aging, The Burnham Institute, 10901 deletion of HIF-1␣ in the brain and exposed them to acute hy- North Torrey Pines Road, La Jolla, CA 92037, E-mail: [email protected]. DOI:10.1523/JNEUROSCI.4555-04.2005 poxic injuries (Dragatsis and Zeitlin, 2000). Surprisingly, mice Copyright © 2005 Society for Neuroscience 0270-6474/05/254099-09$15.00/0 deficient for HIF-1␣ showed significantly less neuronal cell loss in 4100 • J. Neurosci., April 20, 2005 • 25(16):4099–4107 Helton et al. • HIF-1 ␣ Neuroprotection response to hypoxia than control mice using two different para- number of TUNEL-positive cells per total number of cells counted in digms of neuronal hypoxia. Furthermore, gene-expression data matched areas of five sections at 40ϫ magnification. revealed that functional redundancy exists in the adult mouse RNA isolation. Mice were killed by cervical dislocation and dissected as brain, and the predominant role of HIF-1␣ in acute hypoxia is described previously (Sandberg et al., 2000). Tissues were dissected and Ϫ proapoptotic. snap frozen on dry ice. Samples were stored at 80°C until the RNA was isolated using Trizol according to the instructions of the manufacturer. Bilateral common carotid artery occlusion. Mice were anesthetized and Materials and Methods kept in the supine position. Body temperature was maintained by a blan- Generation of mice. All animal procedures were performed according to ket that was servo controlled at 37 Ϯ 1°C by a rectal temperature probe protocols approved by The Salk Institute for Biological Studies and The during the surgery and 1 h after reperfusion. Animals monitored for Burnham Institute Animal Care and Use Committees. Mice with com- longer time periods showed no variations. The common carotid arteries plete deletion of the HIF-1␣ allele (HIF-1␣ ϩ/Neo) were generated by were occluded bilaterally for 75 min. Arterial blood gases and blood replacement with a neomycin resistance gene (NeoR) as described previ- pressure were measured before and during ischemia through the right ously (Ryan et al., 1998). Mice that carried the conditional loxP alleles, femoral artery. We monitored relative cerebral blood flow by laser Dopp- HIF-1␣ alleles flanked by loxP sites (HIF-1␣ F/F), were generated by en- ler flowmetry, as we described previously (Wang et al., 1998), and found ⌬/⌬ F/F gineering a loxP site in the first intron and a loxP-flanked NeoR cassette no significant difference between HIF-1␣ and HIF-1␣ mice. in the second intron as described previously (Ryan et al., 2000). R1ag#5 Seventy-two hours after the procedure, mice were perfused with 4% mice expressing cAMP response element (CRE) under the control of the paraformaldehyde. The brains were dissected and submerged in 4% calcium/calmodulin-dependent kinase CaMKII␣-cre promoter (CAM- paraformaldehyde overnight at 4°C. Coronal sections were cut through CRE) were provided by Dr. Ioannis Dragatsis (University of Tennessee, the forebrain at 50 ␮m intervals with a vibratome. The sections were Memphis, TN) (Dragatsis and Zeitlin, 2000). To generate mice with dried at room temperature for 2 h and stained using acid fusin and cresyl brain predominant HIF-1␣ deletion (HIF-1␣ ⌬/⌬), CAMCRE mice were violet as described previously (Fujii et al., 1997). The grading scale for bred to mice carrying the HIF-1␣ F/F alleles. neuronal damage was as described previously (Fujii et al., 1997): 0, nor- Genotyping. Tail snips were collected from mice at 2 weeks of age for mal; 1, a few (30%) neurons damaged; 2, many neurons (30–70%) dam- genotyping. Tails were collected into lysis buffer, and DNA was isolated aged; and 3, majority of neurons (70%) damaged. All experiments were as described previously (Barlow et al., 1996). Genotyping was performed performed with the investigator blinded as to the genotype of the animal. using PCR. HIF-1␣flox and wild-type (WT) alleles were detected using Microarray analysis. cDNA arrays were used to identify the time of the following primers: HIF-24, GCA GTT AAG AGC ACT AGT TG; maximum overall gene expression in response to a hypoxic insult. Based HIF-25, GGA GCT ATC TCT CTA GAC C; and HIF-26, TTG GGG TGA on our Northern blotting results, HIF-1␣ induction is maximal 1 h after AAA CAT CTG C.
Load more

Recommended publications
  • Single-Cell Expression Profiling Of
    Edinburgh Research Explorer Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene Citation for published version: Elstner, M, Morris, CM, Heim, K, Lichtner, P, Bender, A, Mehta, D, Schulte, C, Sharma, M, Hudson, G, Goldwurm, S, Giovanetti, A, Zeviani, M, Burn, DJ, McKeith, IG, Perry, RH, Jaros, E, Krueger, R, Wichmann, H-E, Schreiber, S, Campbell, H, Wilson, JF, Wright, AF, Dunlop, M, Pistis, G, Toniolo, D, Chinnery, PF, Gasser, T, Klopstock, T, Meitinger, T, Prokisch, H & Turnbull, DM 2009, 'Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene', Annals of Neurology, vol. 66, no. 6, pp. 792-798. https://doi.org/10.1002/ana.21780 Digital Object Identifier (DOI): 10.1002/ana.21780 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: Annals of Neurology Publisher Rights Statement: Published in final edited form as: Ann Neurol. 2009 December ; 66(6): 792–798. doi:10.1002/ana.21780. General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Mouse Ccnl2 Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Ccnl2 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Ccnl2 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Ccnl2 gene (NCBI Reference Sequence: NM_207678 ; Ensembl: ENSMUSG00000029068 ) is located on Mouse chromosome 4. 11 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 11 (Transcript: ENSMUST00000030944). Exon 5 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Ccnl2 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-128M14 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 5 starts from about 37.9% of the coding region. The knockout of Exon 5 will result in frameshift of the gene. The size of intron 4 for 5'-loxP site insertion: 2559 bp, and the size of intron 5 for 3'-loxP site insertion: 2341 bp. The size of effective cKO region: ~565 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 5 11 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Ccnl2 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • PDXK Is Differentially Expressed in the Brains of Patients With
    1 Pyridoxal kinase, encoded by the PDXK gene, is differentially expressed in the brains of patients 2 with schizophrenia. 3 Shahan Mamoor, MS1 4 [email protected] East Islip, NY USA 5 6 Visual and auditory hallucinations are a cardinal feature of psychotic disorders1. We mined published and public microarray datasets2,3 to discover differentially expressed genes in 7 schizophrenia and schizoaffective disorder. We found significant differential expression of the 8 gene encoding pyridoxal kinase, PDXK in neurons of the dorsolateral pre-frontal cortex from 9 patients with schizophrenia and schizoaffective disorder. 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Keywords: schizophrenia, schizoaffective disorder, psychotic disorders, psychosis, systems biology of schizophrenia, PDXK. 28 PAGE 1 OF 12 1 Psychiatric diseases schizophrenia and schizoaffective disorder have in common the 2 existence of psychotic symptoms1,4,5, like visual and auditory hallucinations, that can plague 3 4 affected patients. Understanding the transcriptional profiles of cells and tissues from the brain of 5 patients diagnosed with schizophrenia or schizoaffective disorder has the potential to provide 6 insights into molecular mechanisms underlying disease initiation, progression and associated 7 8 symptoms like psychosis. We mined published and public microarray data from layer 3 and 9 layer 5 pyramidal neurons of the dorsolateral pre-frontal cortex from patients with schizophrenia 10 and schizoaffective disorder and from the layer 3 parvalbumin-positive neurons of the 11 12 dorsolateral prefrontal cortex of patients with schizoaffective disorder to discover genes whose 13 expression was most significantly different in the brains of patients with psychosis at the 14 15 systems-level.
    [Show full text]
  • Gene Expression Responses to DNA Damage Are Altered in Human Aging and in Werner Syndrome
    Oncogene (2005) 24, 5026–5042 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Gene expression responses to DNA damage are altered in human aging and in Werner Syndrome Kasper J Kyng1,2, Alfred May1, Tinna Stevnsner2, Kevin G Becker3, Steen Klvra˚ 4 and Vilhelm A Bohr*,1 1Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA; 2Danish Center for Molecular Gerontology, Department of Molecular Biology, University of Aarhus, DK-8000 Aarhus C, Denmark; 3Gene Expression and Genomics Unit, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA; 4Institute for Human Genetics, University of Aarhus, Denmark The accumulation of DNA damage and mutations is syndromes, caused by heritable mutations inactivating considered a major cause of cancer and aging. While it is proteins that sense or repair DNA damage, which known that DNA damage can affect changes in gene accelerate some but not all signs of normal aging (Hasty expression, transcriptional regulation after DNA damage et al., 2003). Age is associated withan increase in is poorly understood. We characterized the expression of susceptibility to various forms of stress, and sporadic 6912 genes in human primary fibroblasts after exposure to reports suggest that an age-related decrease in DNA three different kinds of cellular stress that introduces repair may increase the susceptibility of cells to agents DNA damage: 4-nitroquinoline-1-oxide (4NQO), c-irra- causing DNA damage. Reduced base excision repair has diation, or UV-irradiation. Each type of stress elicited been demonstrated in nuclear extracts from aged human damage specific gene expression changes of up to 10-fold.
    [Show full text]
  • (PDXK) Human Variants in Drosophila Impacts on Genome Integrity
    www.nature.com/scientificreports OPEN The expression of four pyridoxal kinase (PDXK) human variants in Drosophila impacts on genome Received: 11 July 2019 Accepted: 15 September 2019 integrity Published: xx xx xxxx Elisa Mascolo1, Anna Barile2, Lorenzo Stufera Mecarelli 1, Noemi Amoroso1, Chiara Merigliano3, Arianna Massimi4, Isabella Saggio1,5, Torben Hansen 6, Angela Tramonti7,2, Martino Luigi Di Salvo2, Fabrizio Barbetti4, Roberto Contestabile2 & Fiammetta Vernì 1 In eukaryotes, pyridoxal kinase (PDXK) acts in vitamin B6 salvage pathway to produce pyridoxal 5′-phosphate (PLP), the active form of the vitamin, which is implicated in numerous crucial metabolic reactions. In Drosophila, mutations in the dPdxk gene cause chromosome aberrations (CABs) and increase glucose content in larval hemolymph. Both phenotypes are rescued by the expression of the wild type human PDXK counterpart. Here we expressed, in dPdxk1 mutant fies, four PDXK human variants: three (D87H, V128I and H246Q) listed in databases, and one (A243G) found in a genetic screening in patients with diabetes. Diferently from human wild type PDXK, none of the variants was able to completely rescue CABs and glucose content elicited by dPdxk1 mutation. Biochemical analysis of D87H, V128I, H246Q and A243G proteins revealed reduced catalytic activity and/or reduced afnity for PLP precursors which justify this behavior. Although these variants are rare in population and carried in heterozygous condition, our fndings suggest that in certain metabolic contexts and diseases in which PLP levels are reduced, the presence of these PDXK variants could threaten genome integrity and increase cancer risk. Diferently from bacteria and plants which synthesize ex novo the active form of vitamin B6, pyridoxal 5′ phos- phate (PLP), in other organisms PLP production relies on the salvaging activity of two enzymes: pyridoxal 5′-phosphate kinase (PDXK) and pyridoxine 5′-phosphate oxidase (PNPO).
    [Show full text]
  • "The Genecards Suite: from Gene Data Mining to Disease Genome Sequence Analyses". In: Current Protocols in Bioinformat
    The GeneCards Suite: From Gene Data UNIT 1.30 Mining to Disease Genome Sequence Analyses Gil Stelzer,1,5 Naomi Rosen,1,5 Inbar Plaschkes,1,2 Shahar Zimmerman,1 Michal Twik,1 Simon Fishilevich,1 Tsippi Iny Stein,1 Ron Nudel,1 Iris Lieder,2 Yaron Mazor,2 Sergey Kaplan,2 Dvir Dahary,2,4 David Warshawsky,3 Yaron Guan-Golan,3 Asher Kohn,3 Noa Rappaport,1 Marilyn Safran,1 and Doron Lancet1,6 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel 2LifeMap Sciences Ltd., Tel Aviv, Israel 3LifeMap Sciences Inc., Marshfield, Massachusetts 4Toldot Genetics Ltd., Hod Hasharon, Israel 5These authors contributed equally to the paper 6Corresponding author GeneCards, the human gene compendium, enables researchers to effectively navigate and inter-relate the wide universe of human genes, diseases, variants, proteins, cells, and biological pathways. Our recently launched Version 4 has a revamped infrastructure facilitating faster data updates, better-targeted data queries, and friendlier user experience. It also provides a stronger foundation for the GeneCards suite of companion databases and analysis tools. Improved data unification includes gene-disease links via MalaCards and merged biological pathways via PathCards, as well as drug information and proteome expression. VarElect, another suite member, is a phenotype prioritizer for next-generation sequencing, leveraging the GeneCards and MalaCards knowledgebase. It au- tomatically infers direct and indirect scored associations between hundreds or even thousands of variant-containing genes and disease phenotype terms. Var- Elect’s capabilities, either independently or within TGex, our comprehensive variant analysis pipeline, help prepare for the challenge of clinical projects that involve thousands of exome/genome NGS analyses.
    [Show full text]
  • Comparative Transcriptomics Reveals Similarities and Differences
    Seifert et al. BMC Cancer (2015) 15:952 DOI 10.1186/s12885-015-1939-9 RESEARCH ARTICLE Open Access Comparative transcriptomics reveals similarities and differences between astrocytoma grades Michael Seifert1,2,5*, Martin Garbe1, Betty Friedrich1,3, Michel Mittelbronn4 and Barbara Klink5,6,7 Abstract Background: Astrocytomas are the most common primary brain tumors distinguished into four histological grades. Molecular analyses of individual astrocytoma grades have revealed detailed insights into genetic, transcriptomic and epigenetic alterations. This provides an excellent basis to identify similarities and differences between astrocytoma grades. Methods: We utilized public omics data of all four astrocytoma grades focusing on pilocytic astrocytomas (PA I), diffuse astrocytomas (AS II), anaplastic astrocytomas (AS III) and glioblastomas (GBM IV) to identify similarities and differences using well-established bioinformatics and systems biology approaches. We further validated the expression and localization of Ang2 involved in angiogenesis using immunohistochemistry. Results: Our analyses show similarities and differences between astrocytoma grades at the level of individual genes, signaling pathways and regulatory networks. We identified many differentially expressed genes that were either exclusively observed in a specific astrocytoma grade or commonly affected in specific subsets of astrocytoma grades in comparison to normal brain. Further, the number of differentially expressed genes generally increased with the astrocytoma grade with one major exception. The cytokine receptor pathway showed nearly the same number of differentially expressed genes in PA I and GBM IV and was further characterized by a significant overlap of commonly altered genes and an exclusive enrichment of overexpressed cancer genes in GBM IV. Additional analyses revealed a strong exclusive overexpression of CX3CL1 (fractalkine) and its receptor CX3CR1 in PA I possibly contributing to the absence of invasive growth.
    [Show full text]
  • Chromosome 21 Leading Edge Gene Set
    Chromosome 21 Leading Edge Gene Set Genes from chr21q22 that are part of the GSEA leading edge set identifying differences between trisomic and euploid samples. Multiple probe set IDs corresponding to a single gene symbol are combined as part of the GSEA analysis. Gene Symbol Probe Set IDs Gene Title 203865_s_at, 207999_s_at, 209979_at, adenosine deaminase, RNA-specific, B1 ADARB1 234539_at, 234799_at (RED1 homolog rat) UDP-Gal:betaGlcNAc beta 1,3- B3GALT5 206947_at galactosyltransferase, polypeptide 5 BACE2 217867_x_at, 222446_s_at beta-site APP-cleaving enzyme 2 1553227_s_at, 214820_at, 219280_at, 225446_at, 231860_at, 231960_at, bromodomain and WD repeat domain BRWD1 244622_at containing 1 C21orf121 240809_at chromosome 21 open reading frame 121 C21orf130 240068_at chromosome 21 open reading frame 130 C21orf22 1560881_a_at chromosome 21 open reading frame 22 C21orf29 1552570_at, 1555048_at_at, 1555049_at chromosome 21 open reading frame 29 C21orf33 202217_at, 210667_s_at chromosome 21 open reading frame 33 C21orf45 219004_s_at, 228597_at, 229671_s_at chromosome 21 open reading frame 45 C21orf51 1554430_at, 1554432_x_at, 228239_at chromosome 21 open reading frame 51 C21orf56 223360_at chromosome 21 open reading frame 56 C21orf59 218123_at, 244369_at chromosome 21 open reading frame 59 C21orf66 1555125_at, 218515_at, 221158_at chromosome 21 open reading frame 66 C21orf7 221211_s_at chromosome 21 open reading frame 7 C21orf77 220826_at chromosome 21 open reading frame 77 C21orf84 239968_at, 240589_at chromosome 21 open reading frame 84
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • S41598-021-85062-3.Pdf
    www.nature.com/scientificreports OPEN Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models Justin L. Tosh1,2, Elena R. Rhymes1, Paige Mumford3, Heather T. Whittaker1, Laura J. Pulford1, Sue J. Noy1, Karen Cleverley1, LonDownS Consortium*, Matthew C. Walker4, Victor L. J. Tybulewicz2,5, Rob C. Wykes4,6, Elizabeth M. C. Fisher1* & Frances K. Wiseman3* Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early‑onset Alzheimer’s disease, in which amyloid‑β accumulates in the brain. Amyloid‑β is a product of the chromosome 21 gene APP (amyloid precursor protein) and the extra copy or ‘dose’ of APP is thought to be the cause of this early‑onset Alzheimer’s disease. However, other chromosome 21 genes likely modulate disease when in three‑copies in people with Down syndrome. Here we show that an extra copy of chromosome 21 genes, other than APP, infuences APP/Aβ biology. We crossed Down syndrome mouse models with partial trisomies, to an APP transgenic model and found that extra copies of subgroups of chromosome 21 gene(s) modulate amyloid‑β aggregation and APP transgene‑associated mortality, independently of changing amyloid precursor protein abundance. Thus, genes on chromosome 21, other than APP, likely modulate Alzheimer’s disease in people who have Down syndrome. Down syndrome (DS), which occurs in approximately 1 in 1000 births, is the most common cause of early-onset Alzheimer’s disease-dementia (AD-DS)1. Approximately 6 million people have DS world-wide and by the age of 65 two-thirds of these individuals will have a clinical dementia diagnosis.
    [Show full text]
  • The Crystal Structure of the Plasmodium Falciparum Pdxk Provides an Experimental Model for Pro-Drug Activation
    crystals Brief Report The Crystal Structure of the Plasmodium falciparum PdxK Provides an Experimental Model for Pro-Drug Activation Kai Gao 1 , Wenjia Wang 1 , Thales Kronenberger 2,3 , Carsten Wrenger 3 and Matthew R. Groves 1,* 1 Drug Design XB20, Groningen Research Institute of Pharmacy, University of Groningen, 9700 AD Groningen, The Netherlands; [email protected] (K.G.); [email protected] (W.W.) 2 Department of Medical Oncology & Pneumology, Internal Medicine VIII, University Hospital Tübingen, 72076 Tübingen, Germany; [email protected] 3 Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, 05508-000 São Paulo, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +31-(0)50-363-3305 Received: 2 August 2019; Accepted: 11 October 2019; Published: 17 October 2019 Abstract: Pyridoxine/pyridoxal kinase (PdxK), belongs to the ribokinase family and is involved in the vitamin B6 salvage pathway by phosphorylating 5-pyridoxal (PL) into an active form. In the human malaria parasite, Plasmodium falciparum, Pf PdxK functions to salvage vitamin B6 from both itself and its host. Here, we report the crystal structure of Pf PdxK from P. falciparum in complex with a non-hydrolyzable ATP analog (AMP-PNP) and PL. As expected, the fold is retained and both AMP-PNP and PL occupy the same binding sites when compared to the human ortholog. However, our model allows us to identify a FIxxIIxL motif at the C terminus of the disordered repeat motif (XNXH)m that is implicated in binding the WD40 domain and may provide temporal control of Pf PdxK through an interaction with a E3 ligase complex.
    [Show full text]
  • Tissue-Nonspecific Alkaline Phosphatase
    biomolecules Review Tissue-Nonspecific Alkaline Phosphatase— A Gatekeeper of Physiological Conditions in Health and a Modulator of Biological Environments in Disease Daniel Liedtke 1,* , Christine Hofmann 2, Franz Jakob 3, Eva Klopocki 1 and Stephanie Graser 3 1 Institute for Human Genetics, Biocenter, Julius-Maximilians-University Würzburg, 97074 Würzburg, Germany; [email protected] 2 Section of Pediatric Rheumatology and Osteology, University Children’s Hospital of Würzburg, 97080 Würzburg, Germany; [email protected] 3 Bernhard-Heine-Center for Locomotion Research, Julius-Maximilians-University Würzburg, 97076 Würzburg, Germany; [email protected] (F.J.); [email protected] (S.G.) * Correspondence: [email protected] Received: 30 October 2020; Accepted: 5 December 2020; Published: 8 December 2020 Abstract: Tissue-nonspecific alkaline phosphatase (TNAP) is a ubiquitously expressed enzyme that is best known for its role during mineralization processes in bones and skeleton. The enzyme metabolizes phosphate compounds like inorganic pyrophosphate and pyridoxal-50-phosphate to provide, among others, inorganic phosphate for the mineralization and transportable vitamin B6 molecules. Patients with inherited loss of function mutations in the ALPL gene and consequently altered TNAP activity are suffering from the rare metabolic disease hypophosphatasia (HPP). This systemic disease is mainly characterized by impaired bone and dental mineralization but may also be accompanied by neurological symptoms, like anxiety disorders, seizures, and depression. HPP characteristically affects all ages and shows a wide range of clinical symptoms and disease severity, which results in the classification into different clinical subtypes. This review describes the molecular function of TNAP during the mineralization of bones and teeth, further discusses the current knowledge on the enzyme’s role in the nervous system and in sensory perception.
    [Show full text]